Ace Therapeutics
Advance Your Gastrointestinal & Hepatic Disease Research

Ace Therapeutics is committed to supporting customers to drive scientific innovation and develop novel therapeutics.

Therapeutic Areas

Extensive Expertise in Gastroenterology & Hepatology

At Ace Therapeutics, our team of experts is dedicated to advancing the field of gastrointestinal (GI) and liver disease research. With a profound understanding of these complex disease areas, we provide exceptional preclinical research services and comprehensive drug development support.

GI Diseases

GI Diseases

GRED, Gastric ulcer, gastritis, appendicitis, Crohn disease, IBD, IBS

Liver Diseases

Liver Diseases

NALDs, ALDs, hepatitis, fatty liver, liver Fibrosis, liver failure

Pancreatic Diseases

Pancreatic Diseases

Pancreatitis, pancreatic microcirculation disorder

Biliary Diseases

Biliary Diseases

Cholecystitis, cholangitis, biliary atresia, gallstone

Our Platform

Advanced Methods and Technologies

Ace Therapeutics is at the forefront of gastrointestinal and hepatic disease research, offering a cutting-edge technology platform for preclinical studies and drug development. Our platform integrates advanced methodologies and state-of-the-art technologies to provide comprehensive solutions.

Preclinical Gastrointestinal Function Testing

Preclinical Gastrointestinal Function Testing

Preclinical Liver Function Testing

Preclinical Liver Function Testing

Gastrointestinal Microbiota Research Platform

Gastrointestinal Microbiota Research Platform

Gastrointestinal Simulation Systems

Gastrointestinal Simulation Systems

Biomarker Analysis Technologies

Biomarker Analysis Technologies

Isotope Labeling and Imaging Platform

Isotope Labeling and Imaging Platform